Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
Under a Creative Commons license
open archive
Cited by (0)
Copyright © 2001 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.